A combination of eyelid pressure patching and decellularized, dehydrated pure amniotic membrane basement membrane healed ...

DT-168 is a GeneTAC® small molecule, formulated as an eye drop, that is designed to selectively target the CTG repeat expansion in the TCF4 gene and reduce the expression of the mutant gene product ...

The indication for insertion of ProKera was nonhealing corneal ulcers of ... (1 eye), exposure keratopathy (1 eye), epithelial basement membrane dystrophy (EBMD) with exposure keratopathy (1 ...

Suneel Ram’s needs gradually became greater after he was diagnosed at age 3 with Duchenne muscular dystrophy, a muscle-wasting genetic disorder that afflicts one in 5,000 boys. Today ...

Genetic screening for CTG18.1 expansions can identify patients at elevated risk of vision loss secondary to Fuchs endothelial corneal dystrophy (FECD), according to research published in JAMA ...

It can be hard to tell a scratched cornea (corneal abrasion) from pink eye (also known as conjunctivitis). They can have similar symptoms, including eye redness, tearing, and sensitivity to light.

This study reports a 61-year-old man who developed both corneal deposition and optic neuropathy during systemic amiodarone therapy. We further analyze the clinical features of keratopathy and optic ...

The MIH model did not significantly reduce 30-day readmissions or improve overall health status compared to TOCC. Women and younger patients benefited more from the MIH model, showing reduced ...

Cody native Kelly Tamblyn had looked out at Sunlight Basin many times, but during a trip in 2023 she realized how much she’d been missing. An eye condition was causing her to go blind. She got another ...

My son is 8 and doctors are saving his life but worries we can go extinct from stupidity. He’s not wrong. News Editor Allison Quinn is writing a series of columns about her son’s treatment for ...

William Rivero was diagnosed with Advanced Duchenne Muscular Dystrophy at 18 months old. PORT ST. LUCIE — The city's newest — and youngest — police officer succinctly expressed his feelings ...

In September 2024, Aurion announced the first global commercial launch of this technology, Vyznova™ (which includes neltependocel ), in Japan for the treatment of bullous keratopathy of the cornea.